These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 851643)

  • 1. Circulating anticoagulant in a family with prolonged bleeding time and factor VIII deficiency.
    Diez-Ewald M; Lian EC; Nunez R; Deykin D; Harkness DR
    Blood; 1977 May; 49(5):799-806. PubMed ID: 851643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited combined deficiency of factor V and factor VIII: report of a case with normal factor VIII antigen and ristocetin-induced platelet aggregation.
    Cimo PL; Moake JL; Gonzalez MF; Natelson EA; Fox KR
    Am J Hematol; 1977; 2(4):385-91. PubMed ID: 564138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the hemophilia A carrier state and hemorrhagic thrombocytopathy with dilatation of the platelet membrane complex.
    Melamed I; Djaldetti M; Joshua H; Seligsohn U
    Acta Haematol; 1984; 71(6):381-7. PubMed ID: 6433619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
    Schneider-Trip MD; Jenkins CS; Kahlé LH; Sturk A; ten Cate JW
    Br J Haematol; 1979 Sep; 43(1):99-112. PubMed ID: 508625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
    Poon MC; Wine AC; Ratnoff OD; Bernier GM
    Blood; 1975 Sep; 46(3):409-16. PubMed ID: 50101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome.
    Weiss HJ
    Blood; 1975 Mar; 45(3):403-12. PubMed ID: 1078779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prolonged bleeding time in hemophilia A: comparison of two measuring technics and clinical associations.
    Smith PS; Baglini R; Meissner GF
    Am J Clin Pathol; 1985 Feb; 83(2):211-5. PubMed ID: 3918435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function.
    Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S
    Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paradoxical bleeding as a complication of the treatment of hemophilia with factor VIII and factor IX preparations].
    Sutor AH
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):595-9. PubMed ID: 1714865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P; Tamagnini GL; Dormandy KM
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited platelet abnormalities associated with low factor VIII activity in the same family.
    Ponari O; Civardi E; Megha A; Pini M; Potí R; Dettori AG
    Acta Haematol; 1977 Mar; 57(4):225-32. PubMed ID: 403728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide map analysis of normal plasma and platelet factor VIII antigen.
    Nachman RL; Jaffe EA; Ferris B
    Biochem Biophys Res Commun; 1980 Feb; 92(4):1208-14. PubMed ID: 6768359
    [No Abstract]   [Full Text] [Related]  

  • 19. Procoagulant specificity of factor VIII inhibitor.
    Yang HC; Kuzur M
    Br J Haematol; 1977 Nov; 37(3):429-33. PubMed ID: 304738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined factor V/VIII deficiency: a case report including levels of factor V and factor VIII coagulant and antigen as well as protein C inhibitor.
    Brown JM; Selik NR; Voelpel MJ; Mammen EF
    Am J Hematol; 1985 Dec; 20(4):401-7. PubMed ID: 3934961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.